window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 20, 2026

  • News
  • About Us
Contact Us

Drug Delivery & Formulation

  • CDMOs & Manufacturing,Drug Delivery & Formulation,Medical devices,Pharmaceuticals and therapeutics,Technology and platforms

    MGS launches A.i.r. platform delivering customizable auto-injector solutions

    MGS has launched the A.i.r. Platform, a new customizable auto-injector [...]

    January 19, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Drug Delivery & Formulation,Facilities and infrastructure,Pharmaceuticals and therapeutics,Research & Development

    Vetter advances launch preparations for V-OVS next tamper-evident syringe closure system

    Vetter has reached several development and verification milestones as it [...]

    January 16, 2026
  • Drug Delivery & Formulation,Events and Conferences,Manufacturing,Packaging,Sustainability

    Pharmapack 2026 to return to Paris with focus on GLP-1 therapies and sustainable packaging

    Pharmapack will return to Paris in January 2026, with this [...]

    January 8, 2026
  • Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Nanexa and Moderna sign licence and option agreement for Pharmashell drug delivery development

    Nanexa has entered into a licence and option agreement with [...]

    December 12, 2025
  • Drug Delivery & Formulation,Medical devices,Pharmaceuticals and therapeutics,Technology and platforms

    ACG wins Red Dot Design Award for personalised medicine concept

    ACG, a leading provider of solid-dosage solutions, has received the [...]

    November 6, 2025
  • Biologics & Biosimilars,Biotech,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Technology and platforms

    AmacaThera signs exclusive global licensing agreement with Pacira Biosciences for up to $230 million

    AmacaThera has entered an exclusive worldwide licensing agreement with Pacira [...]

    November 4, 2025
  • Biotech,Drug Delivery & Formulation,Obesity,Pharmaceuticals and therapeutics,Research & Development,Supply Chain & Logistics,Technology and platforms

    Nanexa looks to get under the skin of GLP-1s and beyond

    Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]

    November 4, 2025
  • Central Nervous System,Chronic diseases,Drug Delivery & Formulation,European biotech,Pharmaceuticals and therapeutics

    Neuraxpharm launches next-generation oral fumarate Riulvy for multiple sclerosis in Germany

    Neuraxpharm Group has launched Riulvy (tegomil fumarate) in Germany, marking [...]

    October 3, 2025
  • Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Technology and platforms

    Nanexa secures Japanese patent for PharmaShell technology

    Nanexa has received approval for a Japanese patent covering a [...]

    September 23, 2025
  • Biomanufacturing,Drug Delivery & Formulation,Pharmaceuticals and therapeutics

    Sharp invests $20m in US autoinjector and pen assembly to meet global injectables demand

    Sharp is investing $20 million to expand autoinjector and pen [...]

    September 22, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno Scientific publishes first peer-reviewed data on HDAC inhibitor CS014 showing antithrombotic effects without bleeding risk
    Categories: Biotech, Clinical Development, Drug Development, European biotech, Hematology, Research & Development, Respiratory
  • SPT Labtech adds automated Twist Bioscience NGS library preparation workflows to firefly platform
    Categories: Data Management, Genomics and sequencing, Research & Development, Technology and platforms
  • Almirall to launch phase 3 LumiNE study of lebrikizumab in nummular eczema
    Categories: Clinical Trials, Dermatology, Drug Development, European biotech, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top